Study to Evaluate Dupilumab Monotherapy in Pediatric Patients With Peanut Allergy
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Peanut Allergy
Related studies linked through entity extraction aliases.
A Study to Evaluate Safety, Tolerability and Immune Response in Adolescents Allergic to Peanut After Receiving Intradermal Administration of ASP0892 (ARA-LAMP-vax), a Single Multivalent Peanut (Ara h1, h2, h3) Lysosomal Associated Membrane Protein DNA Plasmid Vaccine
- Status
- COMPLETED
- Phase
- PHASE1
Peanut Oral Immunotherapy Study of Early Intervention for Desensitization
- Status
- COMPLETED
- Phase
- PHASE3
Real World, Open Label, QOL Assessment of Peanut Immunotherapy AR101 in Children and Adolescents
- Status
- TERMINATED
- Phase
- PHASE3
Study in Pediatric Subjects With Peanut Allergy to Evaluate Efficacy and Safety of Dupilumab as Adjunct to AR101 (Peanut Oral Immunotherapy)
- Status
- COMPLETED
- Phase
- PHASE2
Study to Assess Tolerance of Traces in Peanut/Tree Nut Allergic Children.
- Status
- TERMINATED
- Phase
- NA
Clinical Study Using Biologics to Improve Multi OIT Outcomes (COMBINE)
- Status
- COMPLETED
- Phase
- PHASE2
The Grown Up Peanut Immunotherapy Study
- Status
- COMPLETED
- Phase
- NA
Follow up of LEAP Participants and Their Families
- Status
- COMPLETED
- Phase
- N/A
Peanut and Tree Nut Desensitization
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Allergy Experience Study
- Status
- COMPLETED
- Phase
- NA
A Study to Assess the Biological Potency of Peanut Allergen Extract in Adolescent and Adult Peanut Allergic Subjects
- Status
- COMPLETED
- Phase
- PHASE1
AR101 Real-World Open-Label Extension Study
- Status
- COMPLETED
- Phase
- PHASE3
Longer-term Study of AR101 in Subjects Who Participated in a Prior AR101 Study (ARC008)
- Status
- COMPLETED
- Phase
- PHASE3
Salvage Peanut Oral Immunotherapy Study
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Young Children 1-3 Years of Age
- Status
- COMPLETED
- Phase
- PHASE3
ARTEMIS Peanut Allergy In Children
- Status
- COMPLETED
- Phase
- PHASE3
Real-World AR101 Market-Supporting Experience Study in Peanut-Allergic Children (RAMSES)
- Status
- COMPLETED
- Phase
- PHASE3
Evaluating Peanut Immunotherapy Dissolving Film in Healthy Subjects
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Early Peanut Introduction: Translation to Clinical Practice
- Status
- COMPLETED
- Phase
- N/A